Tom Edman
Analyst · Stifel. Please go ahead
Thank you, Sameer. Good afternoon and thank you for joining us for our second quarter 2020 conference call. These continue to be unprecedented times and I hope that all of you and your loved ones are safe and healthy. I'll begin with an update on how COVID-19 has impacted our business, followed by a review of our business strategy, including highlights from the quarter and by a discussion of our second quarter results. Todd Schull, our CFO will follow with an overview of our Q2 2020 financial performance and our Q3 2020 guidance. We will then open the call to your questions. I am pleased to report that in the second quarter of 2020 TTM generated revenues and non-GAAP EPS above the guided range. Our diversified end markets allowed us to grow revenues year-on-year despite weakness in the automotive and commercial aerospace end markets. In addition, strong operational execution overcame production inefficiencies and extra costs due to COVID-19. The COVID-19 pandemic has created operational difficulties, macro-economic uncertainty and employee concerns. I am extremely proud of how TTM employees have worked to deliver excellent performance, despite the formidable and unprecedented challenges of this environment. Finally, I'd like to highlight that we've received the proceeds of the mobile business unit divestiture, and have applied them to repay our Term Loan B, which has driven our net debt to EBITDA ratio to approximately 2.1. have had approximately 65 employees in North America and one in Asia, who have tested positive for COVID-19 this year, with many returning to work after being cleared following testing and quarantine protocols. We continue to use contact tracing and quarantine individuals who were in close contact with the infected team member, in addition to deep cleaning affected work areas. We also continue other measures, such as extensive internal communications, masking, temperature checks and proper distancing in our facilities worldwide. Because of the stringent preventative measures in place, and our culture of transparency and communications, these events have had minimal impact on our manufacturing operations to date. Moving on to the Mobility divestiture, on April 19, we announced that we closed the divestiture of our Mobility business unit to AKMMeadville, a Chinese Consortium for an enterprise value of $645 million. We had previously commented that it could take up to August 7, to receive the proceeds from this transaction due to the process of remitting funds from China to the US. I am pleased to report that we have received the majority of the proceeds earlier than expected and today, we were able to repay $400 million of our term loan. This transaction provides us the balance sheet flexibility to continue the journey to increase TTMs focus on differentiation and less capital intensive, less seasonal, long cycle end markets. Finally on April 29, we issued a press release that discussed the restructuring of our E-MS business unit, this restructuring involved closing two plants and absorbing one into our commercial sector operations. We had said previously that the complete wind down of these two plants would take place through 2020 as we support our customers during their transition to other suppliers, as we support last time buyers for these two plants, we saw sequential growth in Q2. But we continue to be on track for final shipments by the end of 2020. The strategic rationale for this move is based on TTMs increasing focus on differentiated higher margin products such as PCBs and RF components and sub-assemblies. Additionally, local government authorities have communicated to TTM that they intend to expropriate the land where the Shanghai E-M Solutions facility is located. Now I'd like to review our end markets. All historical reported and market disclosures exclude the Mobility business unit. The end market disclosures still contain all of the E-MS segment revenues. For more details on end market disclosures, please refer to our press release for the second quarter earnings. The aerospace and defense end market represented 32% of total second quarter sales, compared to 33% of Q2 2019 sales and 37% of sales in Q12020. We expect sales in Q3 from this end market to represent about 36% of our total sales. We continue to see solid growth in our A&D segment with Q2 revenues up 8% year-on-year and A&D program backlog growing to yet another record level of $647 million compared to $504 million in the year ago quarter. Weakness in the commercial aerospace end market was more than offset by strength and defense. Growth in the defense market is a result of our strong program alignment and key programs for – key bookings for programs such as AESA radar systems in F-35 and F-16 fighter jets. The medical industrial instrumentation end market contributed 21% of our total sales in the second quarter, compared to 17% in the year ago quarter and 18% in the first quarter of 2020. We saw strength in our medical and instrumentation customers that was partially offset by weakness in our industrial customers, particularly in our E-MS segment, as we wind down two of the plants and that business unit. Much of the strength in medical stemmed from the support provided by a number of our facilities to the urgent needs for critical medical equipment, such as ventilators and patient monitoring equipment to combat the pandemic. Our facilities came through in a big way to meet these needs, as we placed first priority on these critical customers. For the third quarter, we expect this market to be 20% of revenues as the year-on-year demand trends from Q2 continue into Q3 albeit at a slower pace. Networking communications accounted for 19% of revenue during the second quarter of 2020. This compares to 19% in the second quarter of 2019 and 16% of revenue in the first quarter of 2020. Year-on-year growth was driven by demand for 5G infrastructure. In Q3, we expect this segment to be 17% of revenue, as deployment for 5G infrastructure takes a pause after a strong first half. Sales in the computing storage peripherals end market represented 13% of total sales in the second quarter, compared to 11% in Q2 of 2019 and 12% in the first quarter of 2020. This end market grew 27% year-on-year from strength in our semiconductor and data center customers. We expect revenues in this end market to represent approximately 12% of third quarter sales. Automotive sales represented 12% of total sales during the second quarter of 2020, compared to 18% in the year ago quarter and 14% during the first quarter of 2020. Automotive sales declined year-over-year due to COVID-19 related OEM factory closures, as well as end market demand weakness. Approximately 40% of the year-on-year decline was due to weakness in the E-MS plants that are being shut down. We expect automotive to contribute 11% of total sales in Q3, with ongoing global weakness in demand expected. We expect our PCB sales in Q3 to decrease by 15% sequentially from the second quarter and to decline year-on-year by approximately 32%. Next, I'll cover some details from the second quarter. Note that all of the following operations and metrics exclude the Mobility business unit. During the quarter, our advanced technology business which includes HDI, Rigid-Flex and RF subsystems and components accounted for approximately 27% of our company's revenue. This compares to approximately 25% in the year ago quarter and 27% in Q1. We are continuing to pursue new business opportunities and increase customer design engagement activities that will leverage our advanced technology capabilities in new markets. Capacity utilization in Asia Pacific was 70% in Q2 compared to 60% in the year ago quarter and 50% in Q1. Our overall capacity utilization in North America was 63% in Q2 compared to 62% in the year ago quarter and 67% in Q1. Our top five customers contributed 26% of total sales in the second quarter of 2020, compared to 31% in the year ago quarter and 32% in the first quarter of 2020. Raytheon technologies was our largest customer accounting for 11% of sales in the second quarter versus 12% in the year ago quarter and 14% in Q1. At the end of Q2, our 90-day backlog which is subject to cancellations was $463.2 million, compared to $416.8 million at the end of the second quarter of last year and $497.7 million at the end of Q1. Our PCB book-to-bill ratio was 1.02 for the three months ending June 29. I think I'd like to conclude by again thanking our employees for continuing to contribute to TTM and our critical mission of inspiring innovation for our customers. Their efforts are particularly appreciated during these times by our customers in critical essential areas like the medical industry. Despite the COVID-19 related challenges we faced in the first half of this year, our businesses performed better than expectations as a direct result of operational excellence, end market diversification and concerted efforts to engage and support our customers. We've also taken positive strategic moves that will strengthen TTM for the long-term. As I look towards the second half and beyond, I am cautiously optimistic about our continued growth prospects in key sub segments such as defense, data center, 5G and medical, while we expect a slower and longer-term recovery in the automotive and commercial aerospace markets. Now Todd will review our financial performance for the second quarter. Todd?